Perspectives: We Need Bold Changes In Order To Bring Down Drug Costs, Not The Tweaks Trump Proposes
Read recent commentaries about drug-cost issues.
The independent source for health policy research, polling, and news.
29,701 - 29,720 of 112,168 Results
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from Massachusetts, California, Michigan, Illinois, Georgia, Rhode Island, Tennessee, Indiana, New Mexico, and Virginia.
Alternative intravenous fluids to the commonly used saline could save up to 70,000 lives a year, a new study finds. In other public health news: smoking while pregnant, memory loss, medical data, ALS, Weight Watchers, the U.S. pregnancy rate, and more.
While many funeral homes get reimbursements for burials or cremations, fewer of them are wiling to offer the services because the funds don't cover ever-rising costs.
The battle between the two chambers has been heating up as they debate a possible expansion of the state's Medicaid program. Medicaid news comes out of Illinois, Ohio and Georgia, as well.
A new report shows that more than 4,500 women crossed into Illinois to terminate a pregnancy in 2016, up from 3,200 the previous year. Outlets report on abortion-related news out of Ohio, Mississippi and Tennessee, as well.
"I'm not spending my time looking for subversion or doing investigations," VA Secretary David Shulkin said. "When it becomes clear to me when people are pursuing different agendas, then I'm going to address that." The secretary, fresh off a travel scandal, has been promising to rout anyone trying to undermine him from his agency goals.
Democrats and liberal activists are no longer satisfied with a strategy that maintains private insurers' primary role. They're starting to focus instead on expanding popular government programs like Medicare and Medicaid.
House Speaker Paul Ryan and Rep. Tom Cole (R-Okla.) both moved to temper enthusiasm about getting any gun control legislation through Congress, despite the surge of public ire following the latest mass school shooting. Meanwhile, lawmakers will meet with President Donald Trump today to discuss ways to battle gun violence.
Lawmakers are aggressively ramping up their efforts to fight the nation's drug epidemic. In addition to the new measure, chairs of the two primary health committees in Congress pledged to push more legislation within the next months.
The lawsuit, pending in Ohio, consolidates more than 400 complaints by cities, counties and Native American tribes nationwide, who are accusing opioid manufacturers and distributors of using misleading marketing to promote the painkillers.
Many Republican-led states are rolling back the law's requirements, while blue states are building up consumer protections. This wildly different strategy will lead to a health care divide in America, experts say. Meanwhile, the legal minds behind the 20-state lawsuit against the health law are painstakingly plotting their path to the Supreme Court. And a look at Idaho's attempts to wiggle out of regulations instituted by the ACA.
Today's early morning highlights from the major news organizations.
Editorial pages highlight these health topics and others.
Media outlets report on news from Massachusetts, Missouri, Texas, Illinois, Ohio, Oregon, California, Colorado, Georgia, Montana, Minnesota, Indiana, Maryland and Virginia.
Those not-quite-right beats that people feel could be absolutely nothing or a sign of a serious problem. In other public health news: autism and ultrasounds, statins, end-of-life discussions, alcohol, standing desks and more.
CNN talks to people addicted to heroin who are still holding down jobs, paying bills and fooling their families. In other news on the national drug crisis: Ohio sues four major opioid distributors; the judge overseeing hundreds of lawsuits against drug companies wants the DEA to release painkiller data; a look at how much the epidemic has cost New York City; and more.
The FDA is looking at why this year's vaccine had a low effectiveness rate. Meanwhile, public officials are trying to make it clear that the vaccine itself can't cause the flu epidemic.
The Pandemic All-Hazards Preparedness Reauthorization Act is up for renewal this year, and drugmakers are already lining up with their hands out. In other pharmaceutical news: a judge rules that Martin Shkreli can be held responsible for $10.4 million in losses related to his tenure at Turing Pharmaceuticals; an analysis finds oversight of compounding pharmacies improved; and a tweet sends one biotech company's stocks soaring.
© 2026 KFF